Company intelligence / Profile preview

Envigo

Indianapolis, Indiana, United States

Ownership: Private
Employees: ~535
Development stage: Other

Overview

Envigo RMS was a contract research organization (CRO) specializing in the breeding and supply of research models and preclinical services for drug development. Formed in 2015, it offered genetically engineered models, laboratory animal services, and specialized diets. Envigo was acquired by Inotiv in November 2021.

Industry: Contract Research Organization

Partnerships

Horizon Discovery Group

Beyond the preview

Go deeper on Envigo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Envigo.

Explore the full profile